prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 263
2022
-
Genetic mechanism for the loss of PRAME in B cell lymphomas
Journal of Clinical Investigation, year: 2022, volume: 132, edition: 14, DOI
-
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL
BLOOD ADVANCES, year: 2022, volume: 6, edition: 18, DOI
-
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing
CANCERS, year: 2022, volume: 14, edition: 13, DOI
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides
Journal of Medicinal Chemistry, year: 2022, volume: 65, edition: 7, DOI
-
Versatile coculture systém to study chronic lymhocytic leukemia proliferation.
Year: 2022, type: Conference abstract
2021
-
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
Blood, year: 2021, volume: 138, edition: 9, DOI
-
FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target.
Year: 2021, type: Conference abstract
-
GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
Year: 2021, type: Conference abstract
-
GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Year: 2021, type: Conference abstract